Equities Analysts Issue Forecasts for Icon PLC’s Q1 2017 Earnings (ICLR)

Posted by on Jul 31st, 2016

Icon PLC (NASDAQ:ICLR) – Stock analysts at Jefferies Group issued their Q1 2017 EPS estimates for shares of Icon PLC in a report issued on Tuesday. Jefferies Group analyst D. Windley expects that the brokerage will post earnings of $1.24 per share for the quarter. Jefferies Group currently has a “Hold” rating and a $80.00 target price on the stock. Jefferies Group also issued estimates for Icon PLC’s Q2 2017 earnings at $1.28 EPS, Q3 2017 earnings at $1.28 EPS and Q4 2017 earnings at $1.30 EPS.

Several other equities analysts have also recently commented on ICLR. KeyCorp reaffirmed a “buy” rating on shares of Icon PLC in a research note on Sunday, May 22nd. SunTrust Banks Inc. reaffirmed a “buy” rating on shares of Icon PLC in a research note on Wednesday, April 27th. Evercore ISI boosted their price objective on shares of Icon PLC from $76.00 to $81.50 and gave the company a “hold” rating in a research note on Tuesday. Robert W. Baird reaffirmed an “outperform” rating and set a $83.00 price objective on shares of Icon PLC in a research note on Monday, June 27th. Finally, Zacks Investment Research cut shares of Icon PLC from a “buy” rating to a “hold” rating in a research note on Wednesday, April 27th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and four have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $78.19.

Shares of Icon PLC (NASDAQ:ICLR) traded up 1.03% during mid-day trading on Thursday, hitting $78.69. 814,239 shares of the company were exchanged. The company’s 50-day moving average price is $69.56 and its 200-day moving average price is $69.56. The firm has a market capitalization of $4.33 billion and a P/E ratio of 18.19. Icon PLC has a 12-month low of $62.31 and a 12-month high of $84.14.

Icon PLC (NASDAQ:ICLR) last issued its quarterly earnings results on Tuesday, July 26th. The company reported $1.14 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.14. The company earned $411 million during the quarter, compared to analyst estimates of $409.97 million. During the same period in the prior year, the business earned $0.95 EPS. The business’s revenue for the quarter was up 5.6% on a year-over-year basis.

ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies.